1. Home
  2. ENTX vs LSBK Comparison

ENTX vs LSBK Comparison

Compare ENTX & LSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTX
  • LSBK
  • Stock Information
  • Founded
  • ENTX 2010
  • LSBK 1891
  • Country
  • ENTX Israel
  • LSBK United States
  • Employees
  • ENTX N/A
  • LSBK N/A
  • Industry
  • ENTX Biotechnology: Biological Products (No Diagnostic Substances)
  • LSBK Savings Institutions
  • Sector
  • ENTX Health Care
  • LSBK Finance
  • Exchange
  • ENTX Nasdaq
  • LSBK Nasdaq
  • Market Cap
  • ENTX 104.0M
  • LSBK 90.0M
  • IPO Year
  • ENTX 2018
  • LSBK 2006
  • Fundamental
  • Price
  • ENTX $1.91
  • LSBK $16.09
  • Analyst Decision
  • ENTX Strong Buy
  • LSBK
  • Analyst Count
  • ENTX 1
  • LSBK 0
  • Target Price
  • ENTX $10.00
  • LSBK N/A
  • AVG Volume (30 Days)
  • ENTX 33.4K
  • LSBK 3.3K
  • Earning Date
  • ENTX 08-08-2025
  • LSBK 07-23-2025
  • Dividend Yield
  • ENTX N/A
  • LSBK 3.38%
  • EPS Growth
  • ENTX N/A
  • LSBK 27.62
  • EPS
  • ENTX N/A
  • LSBK 0.89
  • Revenue
  • ENTX $223,000.00
  • LSBK $25,795,000.00
  • Revenue This Year
  • ENTX N/A
  • LSBK N/A
  • Revenue Next Year
  • ENTX N/A
  • LSBK N/A
  • P/E Ratio
  • ENTX N/A
  • LSBK $17.83
  • Revenue Growth
  • ENTX N/A
  • LSBK N/A
  • 52 Week Low
  • ENTX $1.41
  • LSBK $11.80
  • 52 Week High
  • ENTX $2.79
  • LSBK $16.95
  • Technical
  • Relative Strength Index (RSI)
  • ENTX 44.81
  • LSBK 70.29
  • Support Level
  • ENTX $1.84
  • LSBK $15.68
  • Resistance Level
  • ENTX $2.02
  • LSBK $15.73
  • Average True Range (ATR)
  • ENTX 0.14
  • LSBK 0.08
  • MACD
  • ENTX -0.01
  • LSBK 0.00
  • Stochastic Oscillator
  • ENTX 20.59
  • LSBK 100.00

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

About LSBK Lake Shore Bancorp Inc.

Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.

Share on Social Networks: